Cargando…

Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597

Detalles Bibliográficos
Autores principales: Godugu, Kavitha, El-Far, Ali H., Al Jaouni, Soad, Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785233/
https://www.ncbi.nlm.nih.gov/pubmed/36558202
http://dx.doi.org/10.3390/molecules27248730
_version_ 1784857999188164608
author Godugu, Kavitha
El-Far, Ali H.
Al Jaouni, Soad
Mousa, Shaker A.
author_facet Godugu, Kavitha
El-Far, Ali H.
Al Jaouni, Soad
Mousa, Shaker A.
author_sort Godugu, Kavitha
collection PubMed
description
format Online
Article
Text
id pubmed-9785233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97852332022-12-24 Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597 Godugu, Kavitha El-Far, Ali H. Al Jaouni, Soad Mousa, Shaker A. Molecules Correction MDPI 2022-12-09 /pmc/articles/PMC9785233/ /pubmed/36558202 http://dx.doi.org/10.3390/molecules27248730 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Godugu, Kavitha
El-Far, Ali H.
Al Jaouni, Soad
Mousa, Shaker A.
Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title_full Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title_fullStr Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title_full_unstemmed Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title_short Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
title_sort correction: godugu et al. nanoformulated ajwa (phoenix dactylifera) bioactive compounds improve the safety of doxorubicin without compromising its anticancer efficacy in breast cancer. molecules 2020, 25, 2597
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785233/
https://www.ncbi.nlm.nih.gov/pubmed/36558202
http://dx.doi.org/10.3390/molecules27248730
work_keys_str_mv AT godugukavitha correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597
AT elfaralih correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597
AT aljaounisoad correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597
AT mousashakera correctiongoduguetalnanoformulatedajwaphoenixdactyliferabioactivecompoundsimprovethesafetyofdoxorubicinwithoutcompromisingitsanticancerefficacyinbreastcancermolecules2020252597